Sigma Healthcare Limited

ASX:SIG Stock Report

Market Cap: AU$32.3b

Sigma Healthcare Future Growth

Future criteria checks 3/6

Sigma Healthcare is forecast to grow earnings and revenue by 16.8% and 10.1% per annum respectively. EPS is expected to grow by 16.2% per annum. Return on equity is forecast to be 18.9% in 3 years.

Key information

16.8%

Earnings growth rate

16.22%

EPS growth rate

Healthcare earnings growth17.2%
Revenue growth rate10.1%
Future return on equity18.93%
Analyst coverage

Good

Last updated15 Jun 2026

Recent future growth updates

Recent updates

Analysis Article Feb 05

Calculating The Fair Value Of Sigma Healthcare Limited (ASX:SIG)

Key Insights The projected fair value for Sigma Healthcare is AU$3.12 based on 2 Stage Free Cash Flow to Equity Sigma...
Analysis Article Jan 17

With Sigma Healthcare Limited (ASX:SIG) It Looks Like You'll Get What You Pay For

Sigma Healthcare Limited's ( ASX:SIG ) price-to-earnings (or "P/E") ratio of 62.9x might make it look like a strong...
Analysis Article Nov 20

Sigma Healthcare (ASX:SIG) Has A Rock Solid Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Oct 15

A Look At The Intrinsic Value Of Sigma Healthcare Limited (ASX:SIG)

Key Insights The projected fair value for Sigma Healthcare is AU$3.19 based on 2 Stage Free Cash Flow to Equity Current...
Analysis Article Sep 24

Why We're Not Concerned About Sigma Healthcare Limited's (ASX:SIG) Share Price

When close to half the companies in Australia have price-to-earnings ratios (or "P/E's") below 20x, you may consider...
Analysis Article Aug 30

Sigma Healthcare Limited Just Beat EPS By 7.9%: Here's What Analysts Think Will Happen Next

Investors in Sigma Healthcare Limited ( ASX:SIG ) had a good week, as its shares rose 9.5% to close at AU$3.12...

Earnings and Revenue Growth Forecasts

ASX:SIG - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202813,2511,0159551,04214
6/30/202712,06287480690615
6/30/202610,87473386284015
12/31/20259,547600441488N/A
9/30/20257,774565491543N/A
6/30/20256,002530541599N/A
6/30/20243,294541232273N/A
6/30/20233,091304432445N/A
6/30/20222,993386271284N/A
6/30/20212,420-176305315N/A
6/30/20202,507229252259N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SIG's forecast earnings growth (16.8% per year) is above the savings rate (3.6%).

Earnings vs Market: SIG's earnings (16.8% per year) are forecast to grow faster than the Australian market (12.1% per year).

High Growth Earnings: SIG's earnings are forecast to grow, but not significantly.

Revenue vs Market: SIG's revenue (10.1% per year) is forecast to grow faster than the Australian market (6.3% per year).

High Growth Revenue: SIG's revenue (10.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SIG's Return on Equity is forecast to be low in 3 years time (18.9%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/17 11:26
End of Day Share Price 2026/06/17 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sigma Healthcare Limited is covered by 16 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thomas KierathBarrenjoey Markets Pty Limited
John HesterBell Potter
Lyanne HarrisonBofA Global Research